231 related articles for article (PubMed ID: 15643282)
1. Renal responses to atrial natriuretic peptide are preserved in bilateral ureteral obstruction and augmented by neutral endopeptidase inhibition.
Ryndin I; Gulmi FA; Chou SY; Mooppan UM; Kim H
J Urol; 2005 Feb; 173(2):651-6. PubMed ID: 15643282
[TBL] [Abstract][Full Text] [Related]
2. Volume expansion enhances the recovery of renal function and prolongs the diuresis and natriuresis after release of bilateral ureteral obstruction: a possible role for atrial natriuretic peptide.
Gulmi FA; Matthews GJ; Marion D; von Lutterotti N; Vaughan ED
J Urol; 1995 Apr; 153(4):1276-83. PubMed ID: 7869528
[TBL] [Abstract][Full Text] [Related]
3. Role of atrial peptide in the natriuresis and diuresis that follows relief of obstruction in rat.
Purkerson ML; Blaine EH; Stokes TJ; Klahr S
Am J Physiol; 1989 Apr; 256(4 Pt 2):F583-9. PubMed ID: 2523197
[TBL] [Abstract][Full Text] [Related]
4. Intrarenal hemodynamics and renal function in postobstructive uropathy.
Hsu CH; Kurtz TW; Rosenzweig J; Weller JM
Invest Urol; 1978 Jan; 15(4):348-51. PubMed ID: 627479
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of atrial natriuretic peptide in the kidney of rats with bilateral ureteral obstruction.
Kim SW; Lee J; Park JW; Hong JH; Kook H; Choi C; Choi KC
Kidney Int; 2001 Apr; 59(4):1274-82. PubMed ID: 11260388
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin prevents the downregulation of aquaporin-2 receptor after bilateral ureteral obstruction and protects renal function in a rat model.
Danilovic A; Lopes RI; Sanches TR; Shimizu MH; Oshiro FM; Andrade L; Dénes FT; Seguro AC
Urology; 2012 Aug; 80(2):485.e15-20. PubMed ID: 22503765
[TBL] [Abstract][Full Text] [Related]
7. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
Sansoè G; Aragno M; Mastrocola R; Cutrin JC; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1337-43. PubMed ID: 16449355
[TBL] [Abstract][Full Text] [Related]
9. The renal response to ureteral obstruction.
Wahlberg J
Scand J Urol Nephrol Suppl; 1983; 73():1-30. PubMed ID: 6577583
[TBL] [Abstract][Full Text] [Related]
10. Renal vascular and excretory resistance to atrial natriuretic peptide in pre-cirrhotic, bile-duct ligated rats.
Valdivieso A; Boric MP; Riquelme A; Roblero J
Biol Res; 1993; 26(3):397-404. PubMed ID: 7606260
[TBL] [Abstract][Full Text] [Related]
11. Effects of unilateral or bilateral release of bilateral ureteral obstruction on renal function in rat.
Modi KS; Harris KP; Klahr S
Nephron; 1993; 64(2):235-41. PubMed ID: 8321357
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide-induced changes in renal prostacyclin production in ureteral obstruction.
Himmelstein SI; Coffman TM; Yarger WE; Klotman PE
Am J Physiol; 1990 Feb; 258(2 Pt 2):F281-6. PubMed ID: 2137982
[TBL] [Abstract][Full Text] [Related]
13. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.
Maki T; Horio T; Yoshihara F; Suga S; Takeo S; Matsuo H; Kangawa K
Br J Pharmacol; 2000 Nov; 131(6):1204-10. PubMed ID: 11082129
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
15. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
[TBL] [Abstract][Full Text] [Related]
17. The natriuretic mechanisms of neutral endopeptidase inhibitor in rats.
Shimamoto K; Ura N; Iimura O
Braz J Med Biol Res; 1994 Aug; 27(8):1965-73. PubMed ID: 7749388
[TBL] [Abstract][Full Text] [Related]
18. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
19. [Renal functional reserve in obstructive nephropathy].
Takihana Y; Tago K; Ueno A
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):130-7. PubMed ID: 8139145
[TBL] [Abstract][Full Text] [Related]
20. Renal function after myocardial infarction and cardiac arrest in rats: role of ANP-induced albuminuria?
Nielsen SH; Magid E; Spannow J; Christensen S; Lam HR; Petersen JS
Acta Physiol Scand; 1997 Aug; 160(4):301-10. PubMed ID: 9338510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
